TD Cowen raised the firm’s price target on UnitedHealth (UNH) to $609 from $601 and keeps a Buy rating on the shares. The firm updated its model following Q3 resuls and now look toward the company Investor Day on December 4th for a more definitive view of 2025 EPS, MA enrollment, and incremental updates on MDCD rate environment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Evolent weakness linked to elevated Medicaid MLRs at peers, says Stephens
- UnitedHealth downgraded to Hold from Buy at HSBC (earlier)
- UnitedHealth price target lowered to $625 from $640 at Truist
- UnitedHealth price target lowered to $595 from $615 at RBC Capital
- UnitedHealth price target raised to $644 from $591 at Cantor Fitzgerald
